Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Circulation

• Publication date

  1990-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.CIR.82.5.1754PMID 2171807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thromboxane Mediation of Pulmonary Hemodynamic Responses after Neutralization of Heparin by Protamine in Pigs

  1989cited by this paper
• Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine.

  1989cited by this paper
• Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.

  1989cited by this paper
• Intravascular macrophages in pulmonary capillaries of humans.

  1989cited by this paper
• Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep.

  1988cited by this paper
• Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting.

  1988cited by this paper
• Beneficial Effect of Cyclooxygenase Inhibition on Adverse Hemodynamic Responses after Protamine

  1988cited by this paper
• Acute Pulmonary Vasoconstriction and Thromboxane Release During Protamine Reversal of Heparin Anticoagulation in Awake Sheep: Evidence for the Role of Reactive Oxygen Metabolites Following Nonimmunological Complement Activation

  1988cited by this paper
• Protamine reversal of anticoagulation achieved with a low molecular weight heparin. The effects on eicosanoids, clotting and complement factors.

  1987cited by this paper
• C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin.

  1987cited by this paper
• Heparin-Associated Thrombocytopenia Treatment with Low Molecular Weight Heparin

  1986cited by this paper
• Low-molecular-weight heparin: is small beautiful?

  1986cited by this paper
• Low-Molecular-Weight Heparin

  1986cited by this paper
• Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.

  1986cited by this paper
• Pulmonary intravascular macrophages in sheep. Morphology and function of a novel constituent of the mononuclear phagocyte system.

  1986cited by this paper
• Neutralization of a Low Molecular Weight Heparin (LHN-1) and Conventional Heparin by Protamine Sulfate in Rats

  1986cited by this paper
• Inhibition of low molecular weight heparin by protamine chloride in vivo.

  1985cited by this paper
• Protamine: A Review of its Toxicity

  1985cited by this paper
• A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.

  1985cited by this paper
• A Comparison Between Low Molecular Weight Heparin (KABI 2165) and Standard Heparin in the Intravenous Treatment of Deep Venous Thrombosis

  1985cited by this paper
• Neutralisation of Heparan Sulphate and Low Molecular Weight Heparin by Protamine

  1985cited by this paper
• Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.

  1985cited by this paper
• Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function.

  1985cited by this paper
• Acute reaction to protamine. Its importance to surgeons.

  1984cited by this paper
• Low molecular weight (LMW) heparin derivatives in experimental extra-corporeal circulation (ECC).

  1984cited by this paper
• Low-molecular-weight heparin in extracorporeal circulation.

  1984cited by this paper
• Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture.

  1984cited by this paper
• Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.

  1983cited by this paper
• In vivo complement activation by polyanion--polycation complexes: evidence that C5a is generated intravascularly during heparin--protamine interaction.

  1983cited by this paper
• Plasma Prostaglandin Levels in Rats with Diabetes Mellitus and Diabetic Ketoacidosis

  1982cited by this paper
• Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits.

  1982cited by this paper
• Platelet Factor Four and Protamine Sulfate Neutralization of Heparin Fractionated According to Anionic Charge Density

  1982cited by this paper
• Protamine sulphate hypersensitivity.

  1981cited by this paper
• Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.

  1980cited by this paper
• Anticoagulant Activities of High and Low Molecular Weight Heparin Fractions

  1979cited by this paper
• Polybrene neutralization as a means of monitoring heparin therapy for extracoporeal cirulation.

  1977cited by this paper
• Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III.

  1977cited by this paper
• Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanious and polycations is the presence of C-reactive protein.

  1977cited by this paper
• Pulmonary vasoconstriction produced by protamine and protamine-heparin complex in the isolated cat lung perfused with blood or dextran.

  1975cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Changes in Serum Potassium after Suxamethonium in Children

  1974cited by this paper
• Activated coagulation time of whole blood.

  1966cited by this paper
• RENAL TOXICITY OF POLYBRENE, (HEXADIMETHRINE BROMIDE).

  1965cited by this paper
• RENAL TOXICITY OF POLYBRENE IN OPEN-HEART SURGERY

  1962cited by this paper
• The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

  1961cited by this paper
• A comparison of two heparin-neutralizing agents: protamine and polybrene.

  1960cited by this paper
• Relative antiheparin potency of polybrene and protamine in patients undergoing extracorporeal circulation.

  1959cited by this paper
• Heparin neutralization with polybrene administered intravenously.

  1958cited by this paper

• Syndecans and glycosaminoglycans influence B-cell development and activation

  2025cites this paper
• Protamine Dosing in Cardiac Surgery: Can One Size Fit All?

  2024cites this paper
• A Historical Perspective on the Reversal of Anticoagulants.

  2022cites this paper
• Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice

  2021cites this paper
• Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin

  2020cites this paper
• Self-assembled multivalent (SAMul) ligand systems with enhanced stability in the presence of human serum.

  2019cites this paper
• Hypotension and Transient ST Elevation After Reversal of Heparin With Protamine.

  2018cites this paper
• Trastuzumab-Associated Dermatomyositis.

  2018cites this paper
• Comparative Studies on Biochemical and Pharmacological Profiles of Bovine, Ovine and Porcine Heparins

  2017cites this paper
• Transfusion Medicine and Coagulation Disorders

  2017cites this paper
• Simultaneous estimation of vitamin K1 and heparin with low limit of detection using cascaded channels fiber optic surface plasmon resonance.

  2016cites this paper
• Effect of PEG-PDMAEMA Block Copolymer Architecture on Polyelectrolyte Complex Formation with Heparin.

  2016cites this paper
• Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.

  2015cites this paper
• Nanoscale self-assembled multivalent (SAMul) heparin binders in highly competitive, biologically relevant, aqueous media

  2014cites this paper
• New arginine substituted derivative of poly(allylamine hydrochloride) for heparin reversal

  2014cites this paper
• American Cancer Society (ACS)

  2014cites this paper
• Heparin sensing and binding - taking supramolecular chemistry towards clinical applications.

  2013cites this paper
• Compositional Determinants of the Pharmacological Actions of Heparins

  2012cites this paper
• Cir Euro Template 1

  2007cites this paper
• Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).

  2003cites this paper
• Effect of Calcium Chloride on Protamine Sulfate-Induced Systemic Hypotension in Adult Open-Heart Patients

  2002cites this paper
• Heparin antagonists are potent inhibitors of mast cell tryptase.

  2001cites this paper
• Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.

  2000cites this paper
• Perioperative management of calves undergoing implantation of a left ventricular assist device.

  2000cites this paper
• Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.

  1998cites this paper
• New Concepts in Anticoagulation and Reversal

  1996cites this paper
• The human inflammatory response.

  1996cites this paper
• Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin‐binding EGF‐like growth factor activity

  1995cites this paper
• Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamine.

  1995cites this paper
• Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in rats.

  1995cites this paper
• Protamine-Induced Pulmonary Venoconstriction in Heparinized Pigs

  1995cites this paper
• [Assessment of the performance of sabbatical leave: Hospital Clínic i Provincial of Barcelona (1990-1991). Research Committee of the Hospital Clínic i Provincial of Barcelona].

  1995cites this paper
• Imaging the ovine heparin-protamine interaction with 111In-protamine.

  1993cites this paper
• Protamine and protamine-insulins exacerbate the vascular response to injury.

  1993cites this paper
• Role of platelet-activating factor in the ovine heparin-protamine reaction.

  1992cites this paper
• [The cardiologist and anticoagulants: the heart has its reasons].

  1992cites this paper
• [Complications caused by protamine. 2. Therapy and prevention].

  1991cites this paper
• Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.

  1990cites this paper
• Neutralization of heparin by protamine. Time for a change?

  1990cites this paper